Status:
COMPLETED
Association of Gut Microbiome With Neonatal Complications and Neurodevelopment in Preterm Infants
Lead Sponsor:
Seoul National University Hospital
Conditions:
Preterm Infants
Eligibility:
All Genders
Up to 28 years
Brief Summary
A prospective cohort study investigating the effect of the formation of gut microbiome on the neonatal disease and the prognosis of neurodevelopment in preterm infants.
Detailed Description
The purpose of this study was to investigate the effect of the formation of gut microbiome on the neonatal disease and the prognosis of neurodevelopment in preterm infants.
Eligibility Criteria
Inclusion
- Preterm infants
- born less than 28+0 weeks gestation
Exclusion
- Major congenital anomalies
Key Trial Info
Start Date :
December 4 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 28 2024
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT03841994
Start Date
December 4 2018
End Date
April 28 2024
Last Update
May 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea